BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sun B, Li ZS, Tu ZX, Xu GM, Du YQ. Construction of an oral recombinant DNA vaccine from H pylori neutrophil activating protein and its immunogenicity. World J Gastroenterol 2006; 12(43): 7042-7046 [PMID: 17109503 DOI: 10.3748/wjg.v12.i43.7042]
URL: https://www.wjgnet.com/1007-9327/full/v12/i43/7042.htm
Number Citing Articles
1
Masoud Keikha, Majid Eslami, Bahman Yousefi, Abdolmajid Ghasemian, Mohsen Karbalaei. Potential antigen candidates for subunit vaccine development against Helicobacter pylori infectionJournal of Cellular Physiology 2019; 234(12): 21460 doi: 10.1002/jcp.28870
2
Marina de Bernard, Mario M. D'Elios. The immune modulating activity of the Helicobacter pylori HP-NAP: Friend or foe?Toxicon 2010; 56(7): 1186 doi: 10.1016/j.toxicon.2009.09.020
3
Nasrin Mirzaei, Farkhondeh Poursina, Sharareh Moghim, Niloufar Rashidi, Hajieh Ghasemian Safaei. The study ofH. pyloriputative candidate factors for single- and multi-component vaccine developmentCritical Reviews in Microbiology 2017; 43(5): 631 doi: 10.1080/1040841X.2017.1291578
4
Kanishtha Agarwal, Shvetank Agarwal. Helicobacter pylori Vaccine: From Past to FutureMayo Clinic Proceedings 2008; 83(2): 169 doi: 10.4065/83.2.169
5
Francesca Vallese, Nigam M. Mishra, Matteo Pagliari, Paola Berto, Gaia Codolo, Marina de Bernard, Giuseppe Zanotti. Helicobacter pylori antigenic Lpp20 is a structural homologue of Tipα and promotes epithelial-mesenchymal transitionBiochimica et Biophysica Acta (BBA) - General Subjects 2017; 1861(12): 3263 doi: 10.1016/j.bbagen.2017.09.017
6
Mario Milco D’Elios, Leif P. Andersen. Helicobacter pylori Inflammation, Immunity, and VaccinesHelicobacter 2007; 12(s1): 15 doi: 10.1111/j.1523-5378.2007.00530.x
7
Mariana Ingolotti, Omkar Kawalekar, Devon J Shedlock, Karuppiah Muthumani, David B Weiner. DNA vaccines for targeting bacterial infectionsExpert Review of Vaccines 2010; 9(7): 747 doi: 10.1586/erv.10.57
8
Kanishtha Agarwal, Shvetank Agarwal. Helicobacter pylori Vaccine: From Past to FutureMayo Clinic Proceedings 2008; 83(2): 169 doi: 10.1016/S0025-6196(11)60838-0
9
Xueyong Huang, Bianli Xu, Guangcai Duan, Chunhua Song. The rOmp22–HpaA Fusion Protein Confers Protective Immunity Against Helicobacter pylori in MiceCurrent Microbiology 2013; 67(4): 487 doi: 10.1007/s00284-013-0390-x
10
Armita Balash, Abbas Doosti. Study on the immunogenicity of pcDNA3.1(+)-cagT recombinant vector against Helicobacter pylori in BALB/c miceJournal of Shahrekord University of Medical Sciences 2020; 22(4): 159 doi: 10.34172/jsums.2020.26
11
Xiaoyan Peng, Rongguang Zhang, Guangcai Duan, Chen Wang, Nan Sun, Linghan Zhang, Shuaiyin Chen, Qingtang Fan, Yuanlin Xi. Production and delivery of Helicobacter pylori NapA in Lactococcus lactis and its protective efficacy and immune modulatory activityScientific Reports 2018; 8(1) doi: 10.1038/s41598-018-24879-x
12
Tiruvayipati Suma Avasthi, Niyaz Ahmed. Helicobacter pyloriand Type 1 Diabetes Mellitus: Possibility of Modifying Chronic Disease Susceptibility with Vaccinomics at the AnvilOMICS: A Journal of Integrative Biology 2011; 15(9): 589 doi: 10.1089/omi.2010.0138
13
Elena Alexander. Yeasts in nanotechnology-enabled oral vaccine and gene deliveryBioengineered 2021; 12(1): 8325 doi: 10.1080/21655979.2021.1985816
14
Katayoun Borhani, Ashraf Mohabati Mobarez, Ali Reza Khabiri, Mehrdad Behmanesh, Nima Khoramabadi. Inhibitory effects of rHP-NAP IgY against Helicobacter pylori attachment to AGS cell lineMicrobial Pathogenesis 2016; 97: 231 doi: 10.1016/j.micpath.2016.06.004